DVA

DaVita Inc.

Healthcare
187.89 down -1.92 -1.01% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 12.06B
EV
Shares Out 64.20M
Revenue (ttm) 13.84B
Net Income 781.42M
Beta
P/E 16.20
Forward P/E
EPS (ttm) $10.71
P/S 0.92
P/B -16.76
P/FCF
P/C
EV/Sales
EV/EBITDA
ROA 4.47%
ROE -138.9%
ROIC 13.09%
Gross Margin
Oper. Margin 15.08%
Profit Margin 5.65%
Debt/Eq -17.50
LT Debt/Eq 107.74%
Quick Ratio
Current Ratio 1.42
Book/sh -11.21
Cash/sh 9.56
Div Yield
Div TTM
Payout Ratio
SMA20 -3.24%
SMA50 11.58%
SMA200 35.69%
Volume 925,215
Avg Volume 1.01M
Rel Volume
Perf Week -3.33%
Perf Month 19.64%
Perf Quarter 25.31%
Perf Half Y 60.06%
Perf YTD 65.38%
Perf Year 36.41%
Perf 3Y 89.48%
Perf 5Y 56.21%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

DaVita is a leading healthcare provider focused on transforming care delivery to improve quality of life for patients globally. As a comprehensive kidney care provider, the Company has been a leader in clinical quality and innovation for more than 25 years. DaVita cares for patients at every stage and setting along their kidney health journey - from slowing the progression of kidney disease to helping support transplantation. This includes ensuring patients are supported at home, in dialysis centers, in hospitals, and in skilled nursing facilities. The Company's U.S. dialysis business is a leading provider of kidney dialysis services for patients suffering from end-stage renal disease (ESRD), treating approximately 200,500 patients as of December 31, 2025. The Company's international operations provided dialysis and administrative services to 585 outpatient dialysis centers in 14 countries outside the U.S., serving approximately 94,500 patients. The U.S. integrated kidney care (IKC) business provided integrated care and disease management services to patients in risk-based integrated care arrangements and other integrated care arrangements across the United States. The Company also maintains ancillary services and investments outside of its core U.S. dialysis, U.S. IKC, and international operations.

Name
DaVita Inc.
Industry
Health Care Providers
CEO
Javier J. Rodriguez · Chief Executive Officer
Employees
78,000 as of 2025-12-31
IPO Date
2016-05-10
Phone
(720) 631-2100
Address
2000 16th Street, Denver, CO 80202
Website
http://www.davita.com

Key Executives

Name Title FY Pay
James O. Hearty Chief Compliance Officer
Kathleen A. Waters Chief Medical Officer
David P. Maughan Chief Operating Officer
Joel Ackerman Chief Financial Officer
Javier J. Rodriguez Chief Executive Officer

Latest News